1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one
-
1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one
structure -
-
CAS No:
33743-96-3
-
Formula:
C21H23NO3
-
Chemical Name:
1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one
-
Synonyms:
1-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-3-(3-phenyl-pyrrolidin-1-yl)-propan-1-one; Proroxan [INN]; piroxan; Proroxanum [INN-Latin]; PROROXAN;
-
CAS No:
1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one Basic Attributes
337.41200
337.16779360 g/mol
DTXSID9046285
2934999090
Drug Information
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)|Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
omega-(3'-phenyl-1'-pyrrolidinyl)-6-propionylbenzo(1,4)dioxan
Computed Properties
Molecular Weight:337.4
XLogP3:3.2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:337.16779360
Monoisotopic Mass:337.16779360
Topological Polar Surface Area:38.8
Heavy Atom Count:25
Complexity:448
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation